Analysts expect Syndax Pharmaceuticals Inc to report revenue of 99.54 M for Q4 26, against a range of 94.27 M to 104.82 M. The most recent reported quarter, Q3 26, came in at 83.30 M, a 4.3% miss against the 87.01 M consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 7.68 M | 20.04 M | 37.96 M | 45.87 M | 68.73 M | 64.86 M | 72.79 M | 83.30 M | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 35.44 M | 16.10 M | 27.94 M | 49.16 M | 74.25 M | 77.47 M | 88.39 M | 94.20 M | 104.82 M | 96.83 M | 113.77 M | 123.85 M | 146.62 M | 143.02 M | 171.57 M | 163.17 M | |||||||||
| Low Estimate | 30.75 M | 14.55 M | 23.47 M | 40.79 M | 63.19 M | 69.99 M | 75.50 M | 79.82 M | 94.27 M | 87.68 M | 98.68 M | 109.00 M | 127.91 M | 126.94 M | 143.63 M | 135.69 M | |||||||||
| Consensus Estimate | 33.09 M | 15.32 M | 25.71 M | 44.98 M | 68.72 M | 73.73 M | 81.95 M | 87.01 M | 99.54 M | 92.25 M | 106.22 M | 116.42 M | 137.27 M | 134.98 M | 157.60 M | 149.43 M |
Analysts expect Syndax Pharmaceuticals Inc to report earnings per share of -0.53 for Q4 26, against a range of -0.57 to -0.49. The most recent reported quarter, Q3 26, came in at -0.55, a 17.0% miss against the -0.47 consensus.
| Metric | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.10 | -0.98 | -0.83 | -0.70 | -0.78 | -0.48 | -0.55 | -0.55 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.83 | -1.05 | -0.93 | -0.64 | -0.56 | -0.58 | -0.42 | -0.44 | -0.49 | -0.25 | -0.27 | -0.22 | -0.23 | 0.02 | 0.01 | 0.06 | |||||||||
| Low Estimate | -0.91 | -1.29 | -1.05 | -0.76 | -0.66 | -0.70 | -0.44 | -0.50 | -0.57 | -0.29 | -0.33 | -0.24 | -0.27 | 0.02 | 0.01 | 0.06 | |||||||||
| Consensus Estimate | -0.87 | -1.17 | -0.99 | -0.70 | -0.61 | -0.64 | -0.43 | -0.47 | -0.53 | -0.27 | -0.30 | -0.23 | -0.25 | 0.02 | 0.01 | 0.06 |
Pull Wall Street consensus for Syndax Pharmaceuticals Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=SNDX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "SNDX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=SNDX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();